As a registered stakeholder, the ASPCP will be responding to NICE guidance on cannabis-based products for medicinal use in the field of palliative and supportive care. NICE has released the guidance scope which is open for consultation until 4th Dec. If you would like to contribute to the ASPCP response please comment in the box below or via the contact us form on the website.